Health Discovery Corporation (OTCMKTS:HDVY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
The Board of Directors (the Board) of Health Discovery
Corporation (the Company) voted on Friday, February 24, 2017 to
appoint Mr. George H. McGovern, III as Chairman of the Board and
Chief Executive Officer of the Company. Mr. McGovern has served
as a member of the Board since May 2016. Additionally, Mr.
McGovern will currently forgo any compensation for his services
as Chief Executive Officer of the Company.
Mr. Kevin Kowbel, who had previously served as Chairman and Chief
Executive Officer of the Company, will remain a member of the
Board.
On March 1, 2017, the Board of Health Discovery Corporation
increased the size of the Board of Directors to four directors.
Mr.Marty Delmonte was appointed tothe Board of Directors. Mr.
Delmonte was appointed by a unanimous vote of the directors.
Mr. Delmonte, age 49, has served in various capacities in his
work with the Company since July 2010. Mr. Delmonte has held a
variety of senior executive positions in finance and management
including experience in corporate and investment banking at
numerous financial organizations. Mr. Delmonte earned his B.S.
from the Georgia Institute of Technology.
| Item 9.01. | Financial Statements and Exhibits. |
(a)Not applicable
(b)Not applicable
(c)Not applicable
(d)Exhibits.
None.
About Health Discovery Corporation (OTCMKTS:HDVY)
Health Discovery Corporation (HDC) is a machine learning company that uses mathematical techniques to analyze data to uncover patterns that might otherwise be undetectable. The Company operates primarily in the field of molecular diagnostics where such tools are used for scientific discovery. Its Support Vector Machine (SVM) assets in particular have applicability in various other fields. HDC’s joint venture, SVM Capital, LLC (SVM Capital), applies SVM technology to the financial markets. The Company’s principal asset is its intellectual property, which includes mathematical algorithms called SVM and Fractal Genomic Modeling (FGM), as well as biomarkers that the Company has developed by applying its SVM and FGM techniques to genetic and proteomic data. It also owns the assets of Fractal Genomics, LLC, a company with FGM software. The FGM data analysis technique enables the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases. Health Discovery Corporation (OTCMKTS:HDVY) Recent Trading Information
Health Discovery Corporation (OTCMKTS:HDVY) closed its last trading session 00.0000 at 0.0110 with 6,217 shares trading hands.
